[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Mizuho INAB: Preclinical Data Support Potential Safety Differentiation for INB-619 Full report in bio $INAB $KYMR $ARVN $DNLI $FATE $BMRN $SRPT $ARWR $ALNY $IONS $BLUE $VRTX $EDIT $CRSP $NTLA $BEAM $RGNX $QURE $PGEN $SGMO $ADVM $VERV $PRAX $GLPG $NBIX $ACAD $RARE $VKTX $MOR"
X Link @Biobeats99 2025-10-27T20:43Z XXX followers, XXX engagements
"$INAB - IN8bio Inc. presented preclinical data for its T cell engager program INB-619 showing it effectively eliminated B cells in models of systemic lupus erythematosus with fewer adverse cytokines compared to existing therapies. Read more on"
X Link @visufinance 2025-10-27T19:17Z XXX followers, XX engagements
"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (3/3). $ATOS Phase X $RHHBY Phase X $TRAW Phase X $RARE Phase X $GPCR Phase 2b $ZBIO Phase X $ADCT Phase X $AGIO Phase X $SLS Phase X $PCVX Phase X $ARTV Phase 2a $ALZN Phase X $IMMP Phase 2/3 $ALDX Phase X $TLPH Phase X $INAB Phase X $ALNY Phase X $LLY Phase X $BBIO Phase X $FBIO Phase X $IONS Phase X $REGN Phase 2/3 $CALT Phase X $JAZZ Phase X $GNFT Phase X $NAMS Phase X $PBYI Phase X $KZIA Phase X $NVS Phase X $NAMS Phase X $MRNA Phase X $DNLI Phase 2/3 $LSTA Phase 2b $INKT Phase X $STOK Phase X $ADAG Phase X $PBYI Phase 2"
X Link @BiopharmIQ 2025-10-19T19:11Z 27.6K followers, XXX engagements